Navigation Search

SALIENTVALUE


5 Big Challenges (And Opportunities) In Today’s Independent Pharmacy Marketplace

by Alan J. Hymowitz Volume 5 Issue 15, July 17, 2018  The independent pharmacy marketplace has become one of the most competitive in all of healthcare. Despite the presence of CVS, Walgreen’s and RiteAid on nearly every street corner in America, independent pharmacies are beginning to increase in number. They vary from compounding pharmacies that serve…

READ MORE

6 Ways To “Look Under The Hood” And Build Value In Your SUD Company

by David E. Coit, Jr., DBA, CVA, CVGA, CMAA Volume 5 Issue 13, June 19, 2018  The Substance Use Disorder (SUD) marketplace is dynamic and continues to be impacted by many factors. The valuation of SUD programs is also subject to change, ranging from in-network vs. out-of-network reimbursement and in-house labs to the increasing focus on…

READ MORE

How A Health Care Company Creates Value

by Bill Fotsch and John Case Volume 5 Issue 13, June 19, 2018  Michael Porter, the renowned Harvard Business School professor, famously said that there are only two types of competitive advantage that a company can sustain. It can be the low-cost provider and thus offer lower prices. Or it can somehow differentiate itself from competitors—through…

READ MORE

8 Practical Strategies To Maximize Your Healthcare M+A Success

by Tom Schramski, PhD, CMAA and Joshua Boynton, CMAA Volume 5 Issue 12, June 5, 2018  There is quite a bit written about the failure of mergers and acquisition (M+A) activity, occasionally even competing with President Trump’s tweets. The reasons are as numerous as the transactions themselves, while the analyses tend to focus on sexy megadeals…

READ MORE

7 Insights On Why I/DD M+A Has Just Begun

by Tom Schramski, PhD, CMAA and Joshua Boynton, CMAA Volume 5 Issue 11, May 22, 2018  Just 50 years ago nearly 200,000 people with I/DD were locked up in large institutions across the US. Today, about 27,000 people with I/DD live in such environments, including skilled nursing facilities (SNFs) and other similar institutions. This exodus into…

READ MORE

9 Factors That Are Accelerating Consolidation In US Healthcare

by Tom Schramski, PhD, CMAA Volume 5 Issue 10, May 8, 2018  You cannot escape it, not if you have eyes and ears. The US healthcare market is obsessed with consolidation. Optum (insurance) has acquired Surgical Care Affiliates (ambulatory surgery centers), Cigna (insurance) intends to take over CVS (retail pharmacies) and Express Scripts (pharmacy benefits management),…

READ MORE


5 Reasons Why Consumer Direction Is The #1 Factor In The New I/DD Marketplace

by Tom Schramski, PhD, CMAA and Joshua Boynton, CMAA Volume 5 Issue 8, April 10, 2018  In its purest form, consumer direction means that people have significant decision-making control over the services and products they receive. Most people believe this is a right that we can exercise in whatever marketplace we enter – buying a car,…

READ MORE

8 Ways DME Companies Can Thrive In Tough Times

By Bradley M. Smith, ATP, CMAA and Hilsman Knight, CMAA Volume 5 Issue 7, March 27, 2018  Several years ago, DME competitive bidding was instituted by Medicare and the impact has been dramatic. Many smaller DMEs that could not successfully compete sold their assets, restructured their business, or simply closed their doors. Other DME companies, however, saw an…

READ MORE

6 Reasons Why SUD Referrals Are Headed The Outpatient Way

By Tom Schramski, PhD, CMAA Volume 5 Issue 6, March 13, 2018  Nearly 50 years ago, Anais Nin wrote that “we don’t see things as they are, we see things as we are.” Her observation about human projection fits well for the Substance Use Disorder (SUD) market, where we are in the midst of continuing evolution. One of…

READ MORE